show help

Baba M

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?

Publications:

Title Authors Year Journal
Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase. Baba M 2012 Molecular pharmacology
Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4'-ethynylthymidine analog resistance profile. Baba M 2009 Antimicrobial agents and chemotherapy
Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate. Baba M 2008 Antimicrobial agents and chemotherapy
Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT. Baba M 2007 Antiviral Res
Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates. Baba M 2007 Antimicrobial agents and chemotherapy
4'-Ethynylstavudine (4'-Ed4T) has potent anti-HIV-1 activity with reduced toxicity and shows a unique activity profile against drug-resistant mutants. Baba M 2005 Antivir Chem Chemother
Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants. Baba M 1999 J Med Chem
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains. Baba M 1995 Antimicrobial agents and chemotherapy
Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Baba M 1994 Antimicrobial agents and chemotherapy
Sulfonic acid polymers are potent inhibitors of HIV-1 induced cytopathogenicity and the reverse transcriptases of both HIV-1 and HIV-2. Baba M 1993 Biochimica et biophysica acta
Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase. Baba M 1992 Molecular pharmacology
Potential anti-AIDS naphthalenesulfonic acid derivatives. Synthesis and inhibition of HIV-1 induced cytopathogenesis and HIV-1 and HIV-2 reverse transcriptase activities. Baba M 1992 Journal of medicinal chemistry
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Baba M 1992 Molecular pharmacology
Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives. Baba M 1992 The Journal of biological chemistry
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives. Baba M 1991 Molecular pharmacology
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Baba M 1991 Proceedings of the National Academy of Sciences of the United States of America
Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro. Baba M 1989 Journal of acquired immune deficiency syndromes
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Baba M 1989 Biochemical and biophysical research communications
Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells. Baba M 1989 Journal of acquired immune deficiency syndromes
Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro. Baba M 1989 Biochemical and biophysical research communications
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Baba M 1988 Proceedings of the National Academy of Sciences of the United States of America
Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Baba M 1988 Biochemical and biophysical research communications
Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. Baba M 1987 Antiviral research
All Authors

Using Polbase tables:

Sorting:

Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).

Filtering:

It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.